The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...

Today the market is a SPAC graveyard—with genetics testing startup 23andMe the latest casualty after declaring Chapter 11 bankruptcy late Sunday night. According to new data from the financial ...

In a significant turn of events, the genetic testing company 23andMe announced its filing for Chapter 11 bankruptcy protection on Sunday, marking a profound shift in its operations and strategy. This ...

DNA-testing company 23andMe and its co-founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at factors that ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Mergers with SPACs have been a way for companies to get public-market listings without the heavy scrutiny of the IPO process 23andMe is going bankrupt - underscoring the great risks of investing ...